ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Enhancing Spatial Transcriptomics via Spatially Constrained Matrix Decomposition with EDGES.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Stepwise multi-scale reconstruction of cell spatial organization from single-cell RNA sequencing data with Cell2space.Briefings in bioinformatics · 2026Article
- So3D: a comprehensive three-dimensional spatial omics resource for decoding tissue architecture in physiology and disease.Nucleic acids research · 2026Article
- Enhancing Spatial Transcriptomics via Spatially Constrained Matrix Decomposition with EDGES.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Spatial transcriptomics (ST) technologies revolutionize biomedical research by providing unprecedented insights into tissue architecture and disease mechanisms. While imaging-based ST technologies achieve single-cell spatial resolution, they face inherent limitations in gene detection capacity and measurement accuracy of expression profiles. Although computational approaches make notable progress, current methods remain challenged by insufficient integration of spatial context and systematic biases toward the single-cell RNA sequencing distribution. To address these limitations, EDGES is developed a spatially constrained non-negative matrix factorization framework that simultaneously predicts undetected gene expression and denoises measured transcriptional profiles. EDGES incorporates spatial information through graph Laplacian regularization while synergistically integrating cellular representations with gene-specific representations, thereby ensuring that the predicted gene expression aligns closely with the real ST distribution. Comprehensive evaluations demonstrate that EDGES achieves superior predictive performance and outperforms existing denoising methods. The framework's versatility further facilitates the identification of novel biological markers and spatially resolved expression patterns. With its innovative design, EDGES provides an advanced tool to enhance the reliability of the imaging-based ST data, facilitating more accurate and biologically meaningful interpretation of downstream discoveries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.